ANGIOTENSIN CONVERTING ENZYME INHIBITION AND NOVEL CARDIOVASCULAR RISK BIOMARKERS: Results from the TRAIN study

BACKGROUND: Beneficial effects of angiotensin converting enzyme (ACE) inhibitors seem to be mediated by mechanisms that are partly independent of blood pressure lowering. The present study evaluates effects of an ACE-inhibitor (i.e. fosinopril) intervention on novel cardiovascular risk factors. METH...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Am Heart J
Hauptverfasser: Cesari, Matteo, Kritchevsky, Stephen B., Atkinson, Hal H., Penninx, Brenda W., Di Bari, Mauro, Tracy, Russell P., Pahor, Marco
Format: Artigo
Sprache:Inglês
Veröffentlicht: 2009
Schlagworte:
Article
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC4384444/
https://ncbi.nlm.nih.gov/pubmed/19185642
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ahj.2008.10.026
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge